Results 71 to 80 of about 3,206,553 (301)

Danger Aware Vehicular Networking

open access: yesCoRR, 2020
IEEE 802.11p is one of the key technologies that enable Dedicated Short-Range Communications (DSRC) in intelligent transportation system (ITS) for safety on the road. The main challenge in vehicular communication is the large amount of data to be processed. As vehicle density and velocity increases, the data to be transmitted also increases.
Dessalgn, Tsigigenet, Kim, Seungmo
openaire   +2 more sources

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Vehicular cloud networks: Architecture, applications and security issues [PDF]

open access: yes, 2015
Vehicular Ad Hoc Networks (VANET) are the largest real life application of ad-hoc networks where nodes are represented via fast moving vehicles. This paper introduces the future emerging technology, i.e., Vehicular Cloud Networking (VCN) where vehicles ...
Ahmad, Farhan   +11 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Vehicular cloud networks: Architecture and security

open access: yes, 2015
Cloud computing has been widely adopted across the IT industry due to its scalable, cost-effective, and efficient services. It has many applications in areas such as healthcare, mobile cloud computing (MCC), and vehicular ad hoc networks (VANET ...
Ahmad, Farhan   +7 more
core   +1 more source

Modeling CCH Switch to SCH in IEEE 802.11p/WAVE Vehicular Networks [PDF]

open access: yes, 2017
© 2017 IEEE. Packet collision and packet delay are considered to be critical for safety applications in vehicular networks. This paper designs a new analytical model to evaluate the performance of channel switching for IEEE 802.11p/WAVE in vehicular ...
Liu, RP   +7 more
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

A content dissemination framework for vehicular networking [PDF]

open access: yes, 2010
Vehicular Networks are a peculiar class of wireless mobile networks in which vehicles are equipped with radio interfaces and are, therefore, able to communicate with fixed infrastructure (if available) or other vehicles.
Leontiadis, I.
core  

USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival

open access: yesMolecular Oncology, EarlyView.
CLL cells rely on BCR‐mediated signalling for survival and proliferation in part through suppression of FOXO1. FOXO1 activity is regulated by a plethora of post‐translational modifications including phosphorylation and ubiquitination. We demonstrated that dual inhibition of BCR signalling and the deubiquitinase USP7 activates FOXO1, modulating its ...
Hassan N.B. Almuhanna   +8 more
wiley   +1 more source

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

open access: yesMolecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy